CHLOE BLAST
Overview
CHLOE BLAST is an AI-powered, cloud-based software as a medical device (SaMD) developed by Fairtility, a global leader in transparent AI solutions for reproductive medicine. This innovative tool is designed to provide adjunctive decision support for embryologists and clinicians during In Vitro Fertilization (IVF) procedures.
The system automatically analyzes time-lapse videos of developing embryos, typically retrieved from EmbryoScope Time-Lapse Incubators (TLI) systems. By leveraging convolutional neural networks (CNN), CHLOE BLAST assesses developmental events up to Day 3 to predict an embryo’s likelihood of progressing to the blastocyst stage by Day 5. This objective and data-driven approach aims to enhance the consistency and accuracy of embryo assessment, reducing the subjectivity inherent in traditional manual evaluations.
CHLOE BLAST integrates seamlessly into existing IVF workflows, providing a ‘CHLOE Score’ that aids in the selection of the most viable embryo(s) for transfer or freezing, particularly when multiple embryos are deemed suitable after morphological assessment. The platform is part of Fairtility’s broader CHLOE suite, which seeks to improve IVF outcomes, streamline laboratory efficiency, and foster greater transparency in the patient journey.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered embryo assessment and classification
- Analysis of time-lapse embryo videos from TLI systems
- Prediction of blastocyst development to Day 5
- Provides adjunctive information for embryo selection on Day 3
- Enhances objectivity and consistency in embryo evaluation
- Integrates with IVF workflows and Time-Lapse Incubators (TLI)
- Cloud-based Software as a Medical Device (SaMD)
- Transparent AI for data-driven insights
- Reduces subjective assessment variability among embryologists
- Aids in clinical decision support for embryologists and clinicians
Use Cases
- Optimizing embryo selection in In Vitro Fertilization (IVF)
- Improving IVF success rates and live birth outcomes
- Standardizing embryo assessment across fertility clinics
- Enhancing workflow efficiency for embryologists
- Facilitating transparent communication between clinicians and patients
- Providing data-driven insights for fertility treatment planning
What Physicians Need to Know
Leverage CHLOE Blast™ for objective embryo selection, particularly when multiple embryos appear suitable for transfer, to enhance consistency and potentially improve time to pregnancy. Utilize the transparent AI insights to explain embryo development and implantation potential to patients, fostering trust and informed decision-making. Integrate CHLOE OQ for comprehensive oocyte assessment, especially in fertility preservation and egg donation, to provide evidence-based viability predictions. Regularly review CHLOE KPI™ data to proactively monitor lab performance, identify potential issues, and optimize workflows. The system's ability to automate data entry and provide remote access can free up valuable time for embryologists and clinicians to focus on patient care.
CHLOE Blast™ is a cloud-based software that integrates with Time-Lapse Incubator (TLI) systems, specifically the EmbryoScope version D incubator system, to automatically retrieve images. It offers a vendor-neutral approach for seamless integration with Electronic Medical Record (EMR) systems via APIs, aiming to eliminate manual data entry and mitigate human error. The system provides a web-based user interface accessible via Chrome browsers.
Details
| Category | OB/GYN AI, Radiology & Imaging AI |
| Pricing | Contact vendor for details |
| Deployment | Cloud-based Software as a Medical Device (SaMD), integrates with Time-Lapse Incubator (TLI) systems. |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Obstetrics & Gynecology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2025-08-15 | K243851 510(k) | CHLOE BLAST |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate CHLOE BLAST
Videos
Product demos, reviews, and walkthroughs for CHLOE BLAST.
Fairtility has received FDA clearance on its AI-based embryo assessment tool for IVF, CHLOE Blast.
BiotechTV





